Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives
Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives
复制标题
DOI：
10.1080/13691058.2016.1177203
复制
发表时间：
2016-01-01
影响因子：
2.2
通讯作者：
Potter, Jennifer
中科院分区：
文献类型：
--
作者：
Agenor, Madina;Peitzmeier, Sarah M.;Potter, Jennifer
跨男性人群（出生时被指定为女性但自认为男性或男性的个体）有患宫颈癌的风险。尽管该人群中巴氏试验的使用率较低，但对跨男性个体宫颈癌筛查决定因素的研究却很少。我们对 49 名参与者（32 名跨男性患者和 17 名医疗保健提供者）进行了深入访谈和焦点小组，以检查跨男性个体和医疗保健提供者对宫颈癌风险的看法以及跨男性连续体中个体的筛查。总体而言，患者认为跨男性个体应该定期接受巴氏涂片检查，尤其是在出现妇科问题的情况下。尽管医疗保健提供者的观点各不相同，但许多人认为跨男性个体患宫颈癌的风险较低。与现有的筛查指南相反，一些提供者认为，未与顺性别男性进行阴茎阴道性交、对巴氏试验表示不适或打算进行子宫切除术的跨男性个体可能不需要定期或根本不需要进行筛查。我们的研究结果强调了对患者和医疗服务提供者进行有关跨男性个体宫颈癌风险教育的重要性，并为这一服务不足的人群制定宫颈癌筛查循证指南。
Transmasculine people (individuals assigned a female sex at birth who identify as male or masculine) are at risk of cervical cancer. Despite low rates of Pap test use in this population, research examining the determinants of cervical cancer screening among transmasculine individuals is scarce. We conducted in-depth interviews and focus groups with 49 participants (32 transmasculine patients and 17 healthcare providers) in order to examine transmasculine individuals' and healthcare providers' perceptions of cervical cancer risk and screening among individuals on the transmasculine continuum. Overall, patients believed that transmasculine individuals should receive regular Pap tests, especially in the event of gynaecological concerns. While healthcare providers' views varied, many perceived transmasculine individuals to be at low risk of cervical cancer. Contrary to existing screening guidelines, several providers believed that transmasculine individuals who did not engage in penile-vaginal intercourse with cisgender men, expressed discomfort about Pap testing or intended to obtain a hysterectomy might not need to be screened regularly or at all. Our findings underscore the importance of educating patients and providers about cervical cancer risk among transmasculine individuals and establishing evidence-based guidelines for cervical cancer screening in this underserved population.